Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
No skin whitening treatment gives you permanent results
Lumos Pharma, a company focusing on rare disease treatments, is currently investigating MK-677 in phase-2 clinical trials to evaluate its efficacy in treating childhood-onset GHD [4]
With regular application, users often notice: More even skin tone Reduced appearance of pigmentation Healthier, more luminous skin Because it works gradually, daily application ensures consistent benefits without irritation
Two separate human clinical trials have investigated this compound: Ulcerative Colitis Trial Clinical investigation of this compound in patients with ulcerative colitis examined the compounds GI-protective properties properties that are consistent with its gastric origin and documented activity on intestinal permeability barriers in animal models
US$ 20.57
US$ 22.84
US$ 22.69
